Phospho-Histone H2A.X (Ser139) Antibody

Basic Research Questions

• What is Phospho-Histone H2A.X (Ser139) and why is it significant in DNA damage research?

Phospho-Histone H2A.X (Ser139), commonly referred to as γ-H2AX, is a phosphorylated form of the histone H2A variant that serves as one of the most sensitive markers for DNA double-strand breaks (DSBs) . This phosphorylation occurs rapidly at serine 139 within a highly conserved SQ motif in the C-terminal tail of H2A.X . The phosphorylated form appears within minutes after DNA damage and reaches maximum levels approximately 30 minutes post-damage . Hundreds to thousands of γ-H2AX molecules accumulate around each DSB site, forming nuclear foci that function both to open the chromatin structure and serve as platforms for the recruitment of DNA repair proteins . The importance of γ-H2AX stems from its role in checkpoint-mediated arrest of cell cycle progression and efficient repair of DNA double-strand breaks .

• Which kinases are responsible for H2A.X phosphorylation and what activates them?

H2A.X is phosphorylated primarily by members of the phosphatidylinositol 3-kinase-related protein kinase (PIKK) family:

ATM is considered the major physiological mediator of H2AX phosphorylation in response to DSB formation . It is activated through autophosphorylation at serines 367, 1893, and 1981, causing dissociation of inactive dimers into active monomers . The MRN complex (MRE11-RAD50-NBS1) recognizes DNA damage, recruits ATM to damage sites, and assists in targeting ATM to initiate phosphorylation of substrates including H2AX .

• What detection methods are available for Phospho-Histone H2A.X (Ser139) and how do they compare?

Several methodological approaches can be employed to detect Phospho-Histone H2A.X (Ser139), each with distinct advantages:

The choice of method depends on specific research questions, required sensitivity, and available equipment. For maximum information, combining multiple detection methods is often advantageous.

Advanced Research Questions

• How does the cell cycle affect Phospho-Histone H2A.X (Ser139) levels and what implications does this have for experimental design?

γ-H2AX expression exhibits significant cell cycle dependence that must be considered when designing experiments:

Research has demonstrated that γ-H2AX is most evident in the S-phase fraction of the cell cycle, where DNA replication is actively occurring . Additionally, ATM-dependent phosphorylation of H2AX reaches maximum levels during M phase, even in the absence of exogenous DNA damage . This phosphorylation may contribute to the fidelity of the mitotic process, ensuring faithful transmission of genetic information .

For experimental design, these variations necessitate:

• Cell synchronization when comparing γ-H2AX levels between different treatments

• Inclusion of cell cycle analysis (using DNA content staining) alongside γ-H2AX measurements

• Consideration of background levels in untreated cells, which vary between cell types and cell cycle phases

• Correlation of γ-H2AX signal with other cell cycle markers to accurately interpret results

Failure to account for cell cycle effects can lead to misinterpretation of results, particularly when comparing cell populations with different proliferation rates or cell cycle distributions.

• What are the optimal protocols for measuring γ-H2AX in different experimental contexts, and how should the data be normalized?

The detection of γ-H2AX requires careful optimization based on experimental context:

Cell Culture Protocol:

• Culture cells to approximately 60% confluence (typically 6 × 10^6 cells per T-175 flask)

• Treat with appropriate DNA damaging agent (e.g., 100 μM etoposide)

• Fixation: 1% paraformaldehyde for 10 minutes at room temperature

• Permeabilization: Specific permeabilization buffer (commercial kits typically provide optimized solutions)

• Antibody staining: Use validated anti-phospho-Histone H2A.X (Ser139) antibody at appropriate dilution (typically 1:100 to 1:1000)

• For immunocytochemistry: 2 μg/ml of antibody has been validated for detecting phosphorylated histone H2A.X in HeLa cells treated with staurosporine

• For immunoblot analysis: 0.05-1 μg/ml of antibody has been shown to detect phosphorylated histone H2A.X in acid-extracted histone lysates

Normalization Approaches:

• Flow cytometry: Express as mean fluorescence intensity or percentage of positive cells

• Immunofluorescence: Count the number of foci per nucleus

• Western blotting: Normalize to total H2A.X or other loading controls

• ELISA: Determine the percentage of γ-H2AX by measuring both phosphorylated and total H2AX

The normalization to total H2AX is particularly important as the variability of H2AX expression in different cell and tissue types makes it difficult to interpret the meaning of absolute γ-H2AX levels . The percentage of γ-H2AX provides a normalized value that more accurately represents the amount of DNA damage .

Quality Controls:

• Positive controls: Cells treated with known DNA damaging agents (e.g., etoposide at 100 μM shows clear induction of γ-H2AX)

• Negative controls: Secondary antibody only, untreated cells, and cells with kinase inhibitors that block H2AX phosphorylation

• How do different DNA damaging agents affect the kinetics of Phospho-Histone H2A.X (Ser139) formation and resolution?

Different DNA damaging agents produce distinct patterns of γ-H2AX formation and resolution:

Research using etoposide has shown that when stimulating HeLa cells for 2 hours, a marked increase in phosphorylated H2AX is detected . Dose-response studies determined that the EC50 for etoposide was approximately 38 μM with 2-hour incubation and decreased to approximately 9.4 μM with 24-hour incubation, demonstrating that compound efficacy can be significantly influenced by exposure time .

For gemcitabine, H2AX and ATM phosphorylation were associated with inhibition of DNA synthesis, S-phase accumulation, and activation of the S-phase checkpoint pathway (Chk1/Cdc25A/cyclin-dependent kinase 2) . Notably, exposure to the Chk1 inhibitor 7-hydroxystaurosporine (UCN-01) caused a 10-fold increase in H2AX phosphorylation, which was displayed as an even pan-nuclear staining pattern .

These findings highlight the importance of considering both the mechanism of action of the DNA damaging agent and the timing of analysis when designing experiments to study DNA damage and repair.

• How can researchers distinguish between γ-H2AX signals resulting from DNA damage versus those associated with apoptosis?

The pattern of γ-H2AX staining differs significantly between DNA damage and apoptosis:

Technical approaches to distinguish these signals include:

• Staining pattern analysis: DNA damage typically presents as distinct nuclear foci, while apoptosis produces an even pan-nuclear staining . This distinction can be observed through high-resolution microscopy.

• Multiparameter analysis: Combining γ-H2AX detection with:

  • Apoptosis markers (e.g., Annexin V, cleaved caspase-3)

  • DNA repair proteins (e.g., 53BP1, which colocalizes with damage-induced but not apoptotic γ-H2AX)

  • Nuclear morphology assessment (DAPI staining)

• Timing of analysis: Early time points after treatment are more likely to capture the initial DNA damage response, while later time points may include apoptosis-related phosphorylation.

• Inhibitor studies: Using caspase inhibitors can prevent apoptosis-related H2AX phosphorylation while preserving damage-induced phosphorylation.

Research has shown that exposure of gemcitabine-treated cultures to the Chk1 inhibitor UCN-01 caused a 10-fold increase in H2AX phosphorylation with pan-nuclear staining that was not due to apoptosis-induced DNA fragmentation . Understanding these distinctions is crucial for correctly interpreting γ-H2AX signals in experimental and clinical samples.

• What are the most effective strategies for multiplex analysis of Phospho-Histone H2A.X (Ser139) with other biomarkers?

Multiparameter approaches provide more comprehensive DNA damage response assessment:

Flow cytometry allows simultaneous analysis of multiple parameters at the single-cell level. For example, assessing the correlation between γ-H2AX and cell cycle position has revealed that γ-H2AX is most evident in the S-phase fraction . This approach has also demonstrated that phosphorylation of ATM on Ser1981 is associated with S-phase cells and colocalizes in the nucleus with phosphorylated H2AX foci after gemcitabine exposure .

For imaging-based approaches, sequential immunofluorescence staining may be necessary when antibodies come from the same species. Alternatively, directly conjugated antibodies with different fluorophores can facilitate simultaneous detection. Commercial kits now provide directly conjugated antibodies in various formats, including FITC, Alexa Fluor 488, PE, and APC conjugates , enabling complex multiplex experiments.

Data integration approaches include:

• Bioinformatic analysis of correlations between markers

• Machine learning algorithms for pattern recognition

• Single-cell analysis to identify distinct cellular subpopulations

• Visualization techniques such as t-SNE or UMAP for high-dimensional data

• What are the emerging applications of Phospho-Histone H2A.X (Ser139) measurement in translational and precision medicine research?

Phospho-Histone H2A.X (Ser139) has several emerging applications in translational research:

A particularly promising application is in drug development, where γ-H2AX can serve as a pharmacodynamic biomarker. Structure-activity relationship studies have used γ-H2AX phosphorylation to evaluate anti-neoplastic agents and define EC50 values . By implementing this method, anti-tumor compounds can be rank-ordered to complement SAR campaigns during drug development .

For translational implementation, considerations include:

• Sample type selection (fresh vs. fixed, tumor vs. surrogate tissues)

• Timing of sample collection, especially for monitoring treatment responses

• Standardization approaches using reference standards

• Integration with other molecular biomarkers for comprehensive profiling

Utilization of γ-H2AX as a clinical biomarker requires robust assay validation and standardization, but offers significant potential for personalized therapeutic approaches in oncology and beyond.

• What are the technical challenges in γ-H2AX assay reproducibility and how can researchers address contradictory results?

Several factors can contribute to variability in γ-H2AX assays:

To address contradictory results in the literature:

• Detailed methods reporting: Include specific antibody clones, dilutions, detection methods, and timing of analysis

• Multiple detection approaches: Combine different methods (e.g., flow cytometry and microscopy) to validate findings

• Standardized positive controls: Include cells treated with known DNA damaging agents at defined doses

• Normalization strategies: Express results as percentage of γ-H2AX relative to total H2AX

• Inter-laboratory validation: Perform ring trials or collaborative studies to assess method transferability

• Meta-analysis: Systematically evaluate published data considering methodological differences

A novel ELISA assay has been developed that measures both phosphorylated H2AX and total H2AX to determine the percentage of γ-H2AX, providing a normalized value that better represents the amount of DNA damage . This approach helps address the variability of H2AX expression in different cell and tissue types that makes it difficult to interpret absolute γ-H2AX levels .